https://doi.org/10.4081/mem.2021.945
RU486 between law 194 and new guidelines on voluntary termination of pregnancy through Mifepristone and prostaglandins
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
The article deals with the recent report of the Minister of Health "implementation of the law containing norms for maternity protection and for the voluntary termination of pregnancy (Law 194/78). Final data 2019 and preliminary data 2020", published on September 16 2021. In the light of this document, the author addresses the terms of the debate regarding the "guidelines on the voluntary termination of pregnancy with mifepristone and prostaglandins", published by the Ministry of Health on August 12 2020, by which methods for performing pharmacological abortion using RU486 in Italy have changed. Do they comply with abortion legislation or do they violate it? An adequate answer requires an examination of the ideological currents which are present in Law 194: radical abortionism, collectivism and humanitarianism. The author argues that if we look at the letter of the law there is no doubt that the new guidelines contrast with Law 194, especially in reference to the involvement of consultancies, but at the same time we cannot ignore the fact that in Law 194 there is a hidden radical culture which is manifested in the ministerial guidelines. In any case, the debate on the methods of administering RU486 introduced in August 2020 is an important opportunity to remember that at stake is the right to life of unborn children and the protection of women's physical and mental health.
How to Cite
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
An Open Access Publication is one that meets the following two conditions:
- the author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.
- a complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable open access, unrestricted distribution, interoperability, and long-term archiving.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.